Skip to main content
Clinical Trials/NCT01483716
NCT01483716CompletedNot Applicable

A Trial of Rehabilitation in Obesity Hypoventilation Syndrome (OHS)

Guy's and St Thomas' NHS Foundation Trust1 site in 1 country37 target enrollmentStarted: November 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
37
Locations
1
Primary Endpoint
% Weight loss

Study Overview

Brief Summary

Obesity is an escalating problem in the UK and a proportion of these patients have a condition known as Obesity Hypoventilation Syndrome (OHS). This syndrome is associated with symptoms of breathlessness, reduction in exercise capacity, fatigue and headaches. Previous research has shown that patients with this condition tend to use healthcare services more frequently and are often at risk of other diseases such as diabetes mellitus and high blood pressure. Currently, the mainstay of treatment is noninvasive ventilation (NIV), this is a mask ventilator that patients use overnight to improve oxygen levels and remove carbon dioxide (the waste gas of breathing), however this does not fully treat the underlying problem. The research group has shown that NIV helps improve activity and contributes to weight loss in this group of patients. The aim of this research will be to investigate the effect of an exercise and nutrition programme in addition to NIV on weight loss and activity levels compared to NIV alone.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Diagnosis of OHS
  • •BMI > 30 kg/m2
  • •Chronic hypercapnia , daytime PaCO2 >6kPa
  • •FEV1/FVC ≥70%
  • •Evidence of sleep disordered breathing on overnight studies
  • •Tolerated NIV > 4hrs on 1st night during initiation of NIV

Exclusion Criteria

  • •Hypercapnic respiratory failure secondary to an identifiable cause other than OHS.
  • •Respiratory acidosis (pH <7.35)
  • •Wheelchair/bedbound patients
  • •Cognitive impairment which would prevent the subject from complying with trial protocol
  • •Unstable coronary artery syndrome
  • •Patients postintubation or decannulation following treatment requiring acute hypercapnic respiratory failure
  • •Patients undergoing renal replacement therapy
  • •Critical peripheral vascular disease
  • •Disabling locomotor disability preventing participation in exercises involved in the rehabilitation programme
  • •Pregnancy
  • •Bariatric surgery planned within 3 months

Arms & Interventions

Control

No Intervention

NIV alone

Intervention

Experimental

Rehabilitation arm

Intervention: Rehabilitation (Behavioral)

Outcomes

Primary Outcomes

% Weight loss

Time Frame: 12 months

Secondary Outcomes

  • 6 minute walk test(12 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Swapna Mandal

Clinical Research Fellow

Guy's and St Thomas' NHS Foundation Trust

Study Sites (1)

Loading locations...

Similar Trials